Quick Answer
Telomir Pharmaceuticals, Inc. reported Total Assets of $7.34 million for the year ending 2025.
- Telomir Pharmaceuticals, Inc. showed an increase of +454.5% in Total Assets from 2024 to 2025.
- This data is from Telomir Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $3.50 million | Q2 2024: $2.10 million | Q3 2024: $1.04 million | Q1 2025: $491.2 thousand | Q2 2025: $829.6 thousand | Q3 2025: $7.40 million.
- Over the full 4 years of available data (2022 to 2025), Telomir Pharmaceuticals, Inc.'s Total Assets has grown by 14,965.4%.
- Historical annual values: Fiscal year 2025: $7.34 million | Fiscal year 2024: $1.32 million | Fiscal year 2023: $4.77 million | Fiscal year 2022: $48.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: